About this trial
The EULAR Impact of RMDs Survey collects first-hand information about the impact of rheumatic and musculoskeletal diseases (RMDs) among patients across and beyond Europe. Through periodic questionnaires, patients will provide information about their healthcare situation, and how the disease affects their social and occupational lives. This data will be an important resource for researchers, healthcare professionals, and patients alike, providing valuable insights into the burden of disease and helping improve the overall care for people living with these conditions.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
18-year-old at time of baseline survey
Living in a EULAR country at time of baseline survey
Diagnosed with at least one RMD
Valid personal e-mail address
Disqualifiers
none
Trial population
\- adults with at least 1 RMD
Trial design
Cohort
Prospective
Treatments tested in this trial
Survey
Other interventiononline survey for participants
Treatment groups
Trial outcomes
Primary outcomes
General population description - country
country of residence
General population description - diagnosis
diagnosis (name of the disease)
General population description
year of birth
Secondary outcomes
Diagnosis history - physician treating the RMD
Primary physician specialty treating the patient
Diagnosis history - outpatient care history
number of medical appointments for the past 6 months
Diagnosis history - timeline
waiting time for medical appointments and time spent in medical appointments
Diagnosis history - Inpatient care
number of days of hospitalization during the past 6 months.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.